Form 4: Eli Lilly SVP Sells Shares Under Pre-Arranged 10b5-1 Plan

Eli Lilly's SVP of Finance and CAO, Donald A. Zakrowski, sold 1,000 shares of common stock for $734.93 per share under a pre-arranged 10b5-1 trading plan.

Summary

• Donald A. Zakrowski, Senior Vice President of Finance and Chief Accounting Officer (CAO) of Eli Lilly & Co. (LLY), disposed of 1,000 shares of common stock.
• The transaction occurred on August 28, 2025, at a price of $734.93 per share.
• The sale was executed pursuant to a Rule 10b5-1 trading plan, which was adopted by Mr. Zakrowski on November 20, 2024.
• Following this transaction, Mr. Zakrowski directly beneficially owns 3,839.659 shares of common stock.
• Additionally, Mr. Zakrowski indirectly beneficially owns 1,725.72 shares through a 401(k) plan.

Sentiment

Score: 5

Explanation: The transaction is a pre-scheduled sale under a Rule 10b5-1 plan, which is a common personal financial planning tool for insiders and does not typically signal a change in management's outlook on the company's prospects.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: The sale by a senior executive, even if pre-planned, is generally viewed as a neutral event, as 10b5-1 plans are for personal financial management and do not typically reflect a change in the executive's confidence in the company's future.

Key Dates

Recommendation

The insider sale was conducted under a pre-arranged Rule 10b5-1 trading plan, which is a common practice for executives to manage personal finances and diversify holdings without implying a change in their view of the company's future performance. Therefore, this specific transaction does not provide a strong signal to alter an investment position.

Keywords

Eli Lilly, LLY, Insider Trading, Form 4, Stock Sale, Donald A. Zakrowski, 10b5-1 Plan, SVP Finance, CAO